SCHEMBL3267978

SCHEMBL3267978

Cc1c(C)c(OCc2ccc(Cl)cc2Cl)c(C)c(C)c1C=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
POLB P06746 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
MAPT P10636 1/20 0.52
FABP3 P05413 1/20 0.46
FABP4 P15090 1/20 0.46
FABP5 Q01469 1/20 0.46
IDO1 P14902 2/20 0.45
NR4A2 P43354 2/20 0.45
CYP1A2 P05177 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
BLM P54132 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NR4A1 P22736 1/20 0.42
NR4A3 Q92570 1/20 0.42
GAA P10253 1/20 0.41
KMT2A Q03164 4/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
HDAC8 Q9BY41 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3267648 0.74 MRGPRX4 (0.52) CYP1A2TDP1
SCHEMBL3215715 0.74 ALDH1A1 (0.49) ALDH1A1POLBL3MBTL1MAPTFABP3
SCHEMBL10680066 0.73 KMT2A (0.47) ALDH1A1POLBL3MBTL1MAPTFABP3
SCHEMBL8371564 0.72 POLB (0.54) ALDH1A1POLBL3MBTL1MAPTFABP3
SCHEMBL15678979 0.72 MAPT (0.47) ALDH1A1POLBL3MBTL1MAPTFABP3
SCHEMBL8424941 0.72 NR4A2 (0.62) ALDH1A1POLBL3MBTL1MAPTIDO1
SCHEMBL3208579 0.71 PTGER3 (0.51) ALDH1A1POLBL3MBTL1MAPTFABP3
SCHEMBL3208562 0.71 PTGER3 (0.51) ALDH1A1POLBL3MBTL1MAPTFABP3
SCHEMBL17894446 0.70 FABP3 (0.54) ALDH1A1POLBL3MBTL1MAPTFABP3
SCHEMBL27904820 0.70 ALDH1A1 (0.46) ALDH1A1POLBL3MBTL1MAPTFABP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1914229-B1 NOVEL CERCOSPORAMIDE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2010-06-16 EP disclosed
US-20090036492-A1 Novel Cercosporamide Derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-02-05 US disclosed
EP-1914229-A1 NOVEL CERCOSPORAMIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036492-A1 Novel Cercosporamide Derivative GPR119, CBR3, SLC5A2 ALDH1A1 381/4885POLB 4801/4885L3MBTL1 863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.